Virtu Financial LLC Acer Therapeutics Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.57 - $1.28 $34,835 - $78,227	61,115 New	61,115 $50,000
Q4 2022 Feb 15, 2023	SELL	$1.13 - $4.15 $7,460 - $27,398	-6,602 Reduced 38.48%	10,557 $26,000
Q3 2022 Nov 07, 2022	BUY	$1.28 - $1.6 $8,213 - $10,267	6,417 Added 59.74%	17,159 $24,000
Q2 2022 Aug 09, 2022	BUY	$1.19 - $3.04 $12,782 - $32,655	10,742 New	10,742 $14,000
Q2 2021 Sep 17, 2021	SELL	$2.52 - $3.18 $44,467 - $56,114	-17,646 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$2.47 - $4.39 $43,585 - $77,465	17,646 New	17,646 $55,000
Q3 2019 Nov 20, 2019	SELL	$1.95 - $3.93 $55,608 - $112,071	-28,517 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$3.45 - $26.86 $98,383 - $765,966	28,517 New	28,517 $111,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.